Published • loading... • Updated
Pliant Therapeutics, Inc. (NASDAQ:PLRX) Receives Consensus Recommendation of "Reduce" From Analysts
Summary by MarketBeat
1 Articles
1 Articles
Pliant Therapeutics, Inc. (NASDAQ:PLRX) Receives Consensus Recommendation of "Reduce" from Analysts
Shares of Pliant Therapeutics, Inc. (NASDAQ:PLRX - Get Free Report) have earned a consensus rating of "Reduce" from the four brokerages that are presently covering the company, Marketbeat reports. Two equities research analysts have rated the stock with a sell recommendation, one has assigned a hold
·Sioux Falls, United States
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
